{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:04:16Z","timestamp":1769108656993,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10840-018-0437-9","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T19:43:05Z","timestamp":1536090185000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Eligibility of cardiac resynchronization therapy patients for subcutaneous implantable cardioverter defibrillators"],"prefix":"10.1007","volume":"54","author":[{"given":"Massimo","family":"Giammaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Lucciola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Amellone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Chiarenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariolina","family":"Lovecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"437_CR1","first-page":"1601","volume":"17","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC)endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015;17:1601\u201387.","journal-title":"Europace"},{"key":"437_CR2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","volume":"128","author":"R Weiss","year":"2013","unstructured":"Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944\u201353.","journal-title":"Circulation"},{"key":"437_CR3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jacc.2009.11.029","volume":"55","author":"DS Lee","year":"2010","unstructured":"Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, et al. Evaluation of early complications related to De novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"437_CR4","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.jacc.2006.02.049","volume":"47","author":"MR Reynolds","year":"2006","unstructured":"Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"437_CR5","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA\/ACC\/HRS guideline for Management of Patients with Ventricular Arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm. 2017;(2017 Oct 30)"},{"key":"437_CR6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","volume":"70","author":"L Boersma","year":"2017","unstructured":"Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P, et al. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol. 2017;70:830\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"437_CR7","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.110.976076","volume":"122","author":"JE Poole","year":"2010","unstructured":"Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553\u201361.","journal-title":"Circulation"},{"key":"437_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/europace\/eux089","volume":"19","author":"KH Haugaa","year":"2017","unstructured":"Haugaa KH, Tilz R, Boveda S, Dobreanu D, Sciaraffia E, Mansourati J, et al. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European heart rhythm association survey. Europace. 2017;19:660\u20134.","journal-title":"Europace"},{"key":"437_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1388-9842(02)00204-0","volume":"5","author":"GB Perego","year":"2003","unstructured":"Perego GB, Chianca R, Facchini M, Frattola A, Balla E, Zucchi S, et al. Simultaneous vs. sequential biventricular pacing in dilated cardiomyopathy: an acute hemodynamic study. Eur J Heart Fail. 2003;5:305\u201313.","journal-title":"Eur J Heart Fail"},{"key":"437_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/jce.12343","volume":"25","author":"LR Olde Nordkamp","year":"2014","unstructured":"Olde Nordkamp LR, Warnaars JL, Kooiman KM, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014;25:494\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"437_CR11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/europace\/eut370","volume":"16","author":"DA Randles","year":"2014","unstructured":"Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace. 2014;16:1015\u201321.","journal-title":"Europace"},{"key":"437_CR12","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.hrthm.2014.04.025","volume":"11","author":"CA Groh","year":"2014","unstructured":"Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, et al. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1361\u20136.","journal-title":"Heart Rhythm"},{"key":"437_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/jce.13182","volume":"28","author":"JE Ip","year":"2017","unstructured":"Ip JE, Wu MS, Kennel PJ, et al. Eligibility of pacemaker patients for subcutaneous implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2017;28:544\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"437_CR14","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.hrthm.2015.08.015","volume":"13","author":"DA Theuns","year":"2016","unstructured":"Theuns DA, Burke M, Allavatam V, et al. AB05\u201301: evaluation of a high pass filter designed to reduce oversensing in the S-ICD (abstr.). Heart Rhythm. 2016;13:S10\u20131.","journal-title":"Heart Rhythm"},{"key":"437_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijcard.2015.05.135","volume":"195","author":"LR Olde Nordkamp","year":"2015","unstructured":"Olde Nordkamp LR, Brouwer TF, Barr C, et al. Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management. Int J Cardiol. 2015;195:126\u201333.","journal-title":"Int J Cardiol"},{"key":"437_CR16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.tcm.2016.03.004","volume":"26","author":"ME Willcox","year":"2016","unstructured":"Willcox ME, Prutkin JM, Bardy GH. Recent developments in the subcutaneous ICD. Trends Cardiovasc Med. 2016;26:526\u201335.","journal-title":"Trends Cardiovasc Med"},{"key":"437_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.hrthm.2017.01.022","volume":"14","author":"A Hern\u00e1ndez-Madrid","year":"2017","unstructured":"Hern\u00e1ndez-Madrid A, Facchin D, Klepfer RN, Ghosh S, Mat\u00eda R, Moreno J, et al. Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for efficacy analysis of CRT (OL\u00c9 CRT) study. Heart Rhythm. 2017;14:541\u20137.","journal-title":"Heart Rhythm"},{"key":"437_CR18","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1253\/circj.CJ-16-0153","volume":"80","author":"H Okamura","year":"2016","unstructured":"Okamura H, McLeod CJ, DeSimone CV, et al. Right parasternal lead placement increases eligibility for subcutaneous implantable cardioverter defibrillator therapy in adults with congenital heart disease. Circ J. 2016;80:1328\u201335.","journal-title":"Circ J"},{"key":"437_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.hrcr.2017.02.007","volume":"3","author":"L Santini","year":"2017","unstructured":"Santini L, Pappalardo A, Schirripa V, Danisi N, Forleo GB, Ammirati F. Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators. HeartRhythm Case Rep. 2017;3:286\u20138.","journal-title":"HeartRhythm Case Rep"},{"key":"437_CR20","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/europace\/euv457","volume":"18","author":"FV Tjong","year":"2016","unstructured":"Tjong FV, Brouwer TF, Smeding L, et al. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Europace. 2016;18:1740\u20137.","journal-title":"Europace"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-018-0437-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-018-0437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-018-0437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T23:08:20Z","timestamp":1567552100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-018-0437-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1007\/s10840-018-0437-9","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"24 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients provided written informed consent for data storage and analysis, as approved by the Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M. Lovecchio, S. Chiarenza and S. Valsecchi are employees of Boston Scientific, Inc. No other conflicts of interest exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Local Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}